BOTOX Cosmetic Botulinum Toxin Type A
Materials for Network MembersAdministering BOTOX CosmeticClinical InformationProfessional OrganizationsInformation for Consumers
Materials for Network Members
As a member of the BOTOX® Cosmetic Physicians' Network, you can access materials for your practice, including a customizable newspaper ad, downloadable information for your practice Web site, patient materials, and more.
The Botox Cosmetic Physician Network
Become a member of a distinguished nationwide group of physicians that patients can contact for treatment with BOTOX® Cosmetic. Membership is available to physicians who specialize in facial aesthetic treatments.
About BOTOX Cosmetic
Take a quick treatment tour, get information on administration, including injection and dilution, and review physician and patient assessment of glabellar lines in our clinical studies.

BOTOX® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in patients 18 to 65 years of age.

Important Safety Information

BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation. There have been rare reports of adverse events involving the cardiovascular system. Serious and/or immediate hypersensitivity reactions have been reported rarely. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea.

The most common adverse events following injection include blepharoptosis and nausea. Localized pain, infection, inflammation, tenderness, swelling, erythema and/or bleeding/bruising may be associated with the injection. Patients with neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious adverse events.

Please see the additional safety information and full prescribing information.
Prescribing Information  |  Privacy Policy  |  Contact Allergan  |  Site Map
Allergan  © 2006 Allergan, Inc. Irvine, CA 92612.  ® and ™ marks owned by Allergan, Inc.